Koichi Kawamura

Title: Koichi Kawamura: Innovator in Thrombin Inhibition

Introduction

Koichi Kawamura is a notable inventor based in Mobara, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides with thrombin inhibiting activity. His innovative work has led to the filing of two patents, showcasing his expertise and dedication to advancing scientific knowledge.

Latest Patents

Kawamura's latest patents include a modified HV1-type hirudinin, which features specific amino acid substitutions to enhance its thrombin inhibiting activity. This modified polypeptide is integrated into a secretion plasmid, allowing for efficient expression and secretion in bacteria of the genus Bacillus. The process not only maintains the high activity of the modified hirudinin but also facilitates the large-scale production of desired proteins, such as human growth hormone, by reducing extracellular protease activities in Bacillus subtilis strains.

Career Highlights

Throughout his career, Kawamura has worked with prominent organizations, including Mitsui Toatsu Chemicals and the Agency of Industrial Science and Technology. His experience in these institutions has contributed to his innovative research and development efforts in the field of biotechnology.

Collaborations

Kawamura has collaborated with esteemed colleagues, including Masaru Honjo and Yoshio Furutani. These partnerships have further enriched his research endeavors and have led to advancements in the understanding of thrombin inhibition.

Conclusion

Koichi Kawamura's contributions to the field of biochemistry, particularly through his innovative patents, highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents and biotechnological applications.